Cibus CBUS
NASDAQ CBUS
$1.70 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cibus (CBUS) Shares Outstanding (2016 - 2026)

Cibus (CBUS) posted Shares Outstanding (Entity) of $54.6 million for Q4 2025, little changed sequentially from $54.5 million in Q3 2025, and up 135.14% YoY from $23.2 million in Q4 2024.

Cibus (CBUS) Shares Outstanding (2016 - 2026) Analysis & Trends

Cibus has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $54.6 million in Q4 2025.

  • Quarterly Shares Outstanding (Entity) rose 135.14% year-over-year to $54.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $54.6 million (up 135.14% YoY) and the FY2025 annual result came in at $54.6 million, up 135.14% from the prior year.
  • Shares Outstanding (Entity) was little changed at $54.6 million in Q4 2025 per CBUS's latest filing, from $54.5 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $54.6 million in Q4 2025 and troughed at $743264.0 in Q1 2021.
  • A 5-year average of $16.0 million and a median of $8.2 million in 2023 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2021 and 2024: Shares Outstanding (Entity) increased 4.61% in 2021, then soared 2389.15% in 2024.
  • Over 5 years, Shares Outstanding (Entity) stood at $775480.0 in 2021, then grew by 25.97% to $976896.0 in 2022, then jumped by 955.85% to $10.3 million in 2023, then soared by 125.14% to $23.2 million in 2024, then jumped by 135.14% to $54.6 million in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $54.6 million, $54.5 million, and $41.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.19 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.61 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 445.06 Mn
10 Cibus 129.72 Mn 109.29 Mn - 76.76 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 76.76 Mn
Dec 31, 2025 45.76 Mn
Sep 30, 2025 52.93 Mn
Jun 30, 2025 41.62 Mn
Mar 31, 2025 35.05 Mn
Dec 31, 2024 23.22 Mn
Sep 30, 2024 23.59 Mn
Jun 30, 2024 21.85 Mn
Mar 31, 2024 20.86 Mn
Dec 31, 2023 10.31 Mn
Sep 30, 2023 16.64 Mn
Jun 30, 2023 6.14 Mn
Mar 31, 2023 988,139.00
Dec 31, 2022 919,951.00
Sep 30, 2022 935,689.00
Jun 30, 2022 933,270.00
Mar 31, 2022 840,402.00
Dec 31, 2021 749,515.00
Sep 30, 2021 745,594.00
Jun 30, 2021 743,987.00